NCT05269381
- Conditions
- Adenocarcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, +168 more
- Locations
-
- Mayo Clinic in Florida Jacksonville, Florida, United States
Clinical trial condition
Clinical Stage III Cutaneous Melanoma AJCC v8
Explore clinical trials studying Clinical Stage III Cutaneous Melanoma AJCC v8. Study availability and eligibility vary by location and protocol.
31 public trials
7 recruiting studies
Clinical Stage III Cutaneous Melanoma AJCC v8 trial results
NCT05136196
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Clinical Stage III Cutaneous Melanoma AJCC v8, +52 more
- Locations
-
- Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
- University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
- Tower Cancer Research Foundation Beverly Hills, California, United States
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
NCT05896839
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Basal Cell, +34 more
- Locations
-
- UC San Diego Moores Cancer Center La Jolla, California, United States
- Keck Medicine of USC Koreatown Los Angeles, California, United States
- Los Angeles General Medical Center Los Angeles, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
NCT03819296
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +61 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT06075524
- Conditions
- Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Locally Advanced Lung Carcinoma, +28 more
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
NCT06265285
- Conditions
- Adenocarcinoma, Advanced Esophageal Squamous Cell Carcinoma, Advanced Renal Cell Carcinoma, +81 more
- Locations
-
- Mayo Clinic in Florida Jacksonville, Florida, United States
Recruiting
IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors
NCT05039801
- Conditions
- Adnexal Diseases, Advanced Endometrial Carcinoma, Advanced Head and Neck Squamous Cell Carcinoma, +71 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Not yet recruiting
Circadian-Optimized Light Therapy for the Treatment of Patients With Advanced Melanoma Receiving Tumor-Infiltrating Lymphocyte Therapy
NCT07628894
- Conditions
- Advanced Cutaneous Melanoma, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, +13 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Not yet recruiting
Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial
NCT07576725
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +119 more
- Locations
-
- Uganda Cancer Institute Kampala, Uganda
Active, not recruiting
Physician/Patient Choice of Either High-Dose Recombinant Interferon Alfa-2B or Ipilimumab, Versus Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery
NCT02506153
- Conditions
- Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Melanoma, +18 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Cancer Center at Saint Joseph's Phoenix, Arizona, United States
- Virginia G Piper Cancer Care-Del Camino Scottsdale, Arizona, United States
- Banner University Medical Center - Tucson Tucson, Arizona, United States